Smith RC - Search Results

1

Classification of pancreatic cystic lesions using SELDI-TOF mass spectrometry.

Scarlett CJ, Samra JS, Xue A, Baxter RC, Smith RC. Scarlett CJ, et al. Among authors: smith rc. ANZ J Surg. 2007 Aug;77(8):648-53. doi: 10.1111/j.1445-2197.2007.04179.x. ANZ J Surg. 2007. PMID: 17635277

2

Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.

Scarlett CJ, Smith RC, Saxby A, Nielsen A, Samra JS, Wilson SR, Baxter RC. Scarlett CJ, et al. Among authors: smith rc. Gastroenterology. 2006 May;130(6):1670-8. doi: 10.1053/j.gastro.2006.02.036. Epub 2006 Mar 6. Gastroenterology. 2006. PMID: 16697731

3

Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.

Scarlett CJ, Saxby AJ, Nielsen A, Bell C, Samra JS, Hugh T, Baxter RC, Smith RC. Scarlett CJ, et al. Among authors: smith rc. Hepatology. 2006 Sep;44(3):658-66. doi: 10.1002/hep.21294. Hepatology. 2006. PMID: 16941699

4

Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS.

Xue A, Gandy RC, Chung L, Baxter RC, Smith RC. Xue A, et al. Among authors: smith rc. Pancreatology. 2012 Mar-Apr;12(2):124-9. doi: 10.1016/j.pan.2012.02.009. Epub 2012 Feb 21. Pancreatology. 2012. PMID: 22487522

5

SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort.

Schlichtemeier SM, Nahm CB, Xue A, Gill AJ, Smith RC, Hugh TJ. Schlichtemeier SM, et al. Among authors: smith rc. J Surg Res. 2019 Jun;238:127-136. doi: 10.1016/j.jss.2019.01.008. Epub 2019 Feb 13. J Surg Res. 2019. PMID: 30771682

6

Control of venous bleeding during dissection near the head of the pancreas.

Samra JS, Smith RC. Samra JS, et al. Among authors: smith rc. ANZ J Surg. 2003 Oct;73(10):856-7. doi: 10.1046/j.1445-2197.2003.02755.x. ANZ J Surg. 2003. PMID: 14525584

7

Hemosuccus pancreaticus.

Callinan AM, Samra JS, Smith RC. Callinan AM, et al. Among authors: smith rc. ANZ J Surg. 2004 May;74(5):395-7. doi: 10.1111/j.1445-1433.2004.02999.x. ANZ J Surg. 2004. PMID: 15144274 No abstract available.

8

Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma.

Xue A, Chang JW, Chung L, Samra J, Hugh T, Gill A, Butturini G, Baxter RC, Smith RC. Xue A, et al. Among authors: smith rc. Br J Cancer. 2012 Nov 20;107(11):1883-91. doi: 10.1038/bjc.2012.458. Br J Cancer. 2012. PMID: 23169340 Free PMC article.

9

High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma.

Smith R, Xue A, Gill A, Scarlett C, Saxby A, Clarkson A, Hugh T. Smith R, et al. World J Surg. 2007 Mar;31(3):493-502; discussion 503. doi: 10.1007/s00268-006-0289-9. World J Surg. 2007. PMID: 17219285

10

Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.

Nielsen A, Scarlett CJ, Samra JS, Gill A, Li Y, Allen BJ, Smith RC. Nielsen A, et al. Among authors: smith rc. J Gastroenterol Hepatol. 2005 Feb;20(2):256-63. doi: 10.1111/j.1440-1746.2004.03531.x. J Gastroenterol Hepatol. 2005. PMID: 15683429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

980 results

Search Page

Filters